inositol has been researched along with Cardiovascular Diseases in 20 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We enrolled 47 Japanese patients with type 2 diabetes, with HbA1c levels with 7." | 2.79 | Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients. ( Fuchigami, M; Goda, T; Hariya, N; Inoue, S; Mochizuki, K; Osonoi, T; Saito, M, 2014) |
| "Myo-inositol has documented in clinical studies its effectiveness in improving the metabolic syndrome in post menopausal women." | 2.50 | Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause. ( Parazzini, F, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hedrington, MS | 1 |
| Davis, SN | 1 |
| Asakura, M | 1 |
| Kim, J | 1 |
| Asanuma, H | 1 |
| Hamasaki, T | 1 |
| Tsukahara, K | 1 |
| Higashino, Y | 1 |
| Ishikawa, T | 1 |
| Nakama, Y | 1 |
| Koba, S | 1 |
| Maruyama, Y | 1 |
| Tsujimoto, M | 1 |
| Himeno, H | 1 |
| Ohkusa, T | 1 |
| Fujino, S | 1 |
| Shimizu, M | 1 |
| Endo, T | 1 |
| Yoda, S | 1 |
| Muroya, T | 1 |
| Murohara, T | 1 |
| Ohte, N | 1 |
| Suzuki, H | 1 |
| Kohno, T | 1 |
| Fukui, K | 1 |
| Shiono, T | 1 |
| Takase, H | 1 |
| Uzui, H | 1 |
| Nagai, Y | 1 |
| Hashimoto, Y | 1 |
| Ikeda, S | 1 |
| Mizuno, S | 1 |
| Tamita, K | 1 |
| Fujita, M | 1 |
| Satake, K | 1 |
| Kinoshita, Y | 1 |
| Nunohiro, T | 1 |
| Sakagami, S | 1 |
| Higaki, J | 1 |
| Morii, I | 1 |
| Sawada, R | 1 |
| Hiasa, Y | 1 |
| Shigemasa, T | 1 |
| Nakahama, M | 1 |
| Sata, M | 1 |
| Doi, O | 1 |
| Ueda, T | 1 |
| Yamada, T | 1 |
| Yamanouchi, T | 1 |
| Yamaguchi, H | 1 |
| Morita, Y | 1 |
| Hayashi, H | 1 |
| Kitakaze, M | 1 |
| Ferrer, MD | 1 |
| Ketteler, M | 1 |
| Tur, F | 1 |
| Tur, E | 1 |
| Isern, B | 1 |
| Salcedo, C | 1 |
| Joubert, PH | 1 |
| Behets, GJ | 1 |
| Neven, E | 1 |
| D'Haese, PC | 1 |
| Perelló, J | 1 |
| Minozzi, M | 1 |
| Nordio, M | 1 |
| Pajalich, R | 1 |
| Unfer, V | 1 |
| Porcaro, G | 1 |
| Hariya, N | 1 |
| Mochizuki, K | 1 |
| Inoue, S | 1 |
| Saito, M | 1 |
| Fuchigami, M | 1 |
| Goda, T | 1 |
| Osonoi, T | 1 |
| Parazzini, F | 1 |
| Kawamori, R | 2 |
| Tajima, N | 1 |
| Iwamoto, Y | 1 |
| Kashiwagi, A | 1 |
| Shimamoto, K | 1 |
| Kaku, K | 1 |
| Napoli, C | 1 |
| Sessa, M | 1 |
| Infante, T | 1 |
| Casamassimi, A | 1 |
| Standl, E | 1 |
| Schnell, O | 1 |
| SCHOGER, GA | 3 |
| SCHOGER-VON SCHOLZ, I | 1 |
| Kadowaki, T | 1 |
| Ishida, H | 1 |
| Kim, JI | 1 |
| Kim, JC | 1 |
| Kang, MJ | 1 |
| Lee, MS | 1 |
| Kim, JJ | 1 |
| Cha, IJ | 1 |
| Holub, BJ | 1 |
| Radhakrishnamurthy, B | 1 |
| Berenson, GS | 1 |
| Pargaonkar, PS | 1 |
| Voors, AW | 1 |
| Srinivasan, SR | 1 |
| Plavidal, F | 1 |
| Dolan, P | 1 |
| Dalferes, ER | 1 |
| Richard, A | 1 |
| Schütz, E | 1 |
| Brandt, H | 1 |
| Fromm, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Japan Working Group for the Assessment That the Alpha-glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT[NCT00212017] | 3,000 participants (Actual) | Interventional | 2005-04-30 | Terminated (stopped due to We obtained the final results due to the interim analysis.) | |||
| Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.[NCT01839344] | Phase 2 | 19 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes: a Randomized, Placebo-controlled, Double-blind, Parallel Group Clinical Trial[NCT00820807] | 60 participants (Anticipated) | Interventional | 2009-01-31 | Terminated (stopped due to Stopped due to a non-safety-related issue with the beverage (test vehicle).) | |||
| Effects of Different Doses of Pinitol on Carbohydrate Metabolism Parameters in Healthy Subjects: a Randomized Cross-over Placebo-controlled Study[NCT01738763] | 30 participants (Actual) | Interventional | 2011-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for inositol and Cardiovascular Diseases
| Article | Year |
|---|---|
Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type | 2019 |
Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
Topics: Animals; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Inositol; Insulin Resis | 2014 |
Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause.
Topics: Animals; Cardiovascular Diseases; Cell Line; Female; Humans; Inositol; Mice; Osteoporosis, Postmenop | 2014 |
Unraveling framework of the ancestral Mediator complex in human diseases.
Topics: Animals; Cardiovascular Diseases; Catechols; Humans; Inositol; Mediator Complex; Metabolic Diseases; | 2012 |
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation.
Topics: 1-Deoxynojirimycin; Acarbose; Cardiovascular Diseases; Diabetes Complications; Glycoside Hydrolase I | 2012 |
The nutritional significance, metabolism, and function of myo-inositol and phosphatidylinositol in health and disease.
Topics: 6-Phytase; Animals; Biological Transport; Birds; Brain Chemistry; Cardiovascular Diseases; Chemical | 1982 |
4 trials available for inositol and Cardiovascular Diseases
| Article | Year |
|---|---|
Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?
Topics: Aged; Cardiovascular Diseases; Female; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; | 2017 |
Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Asian People; Blood Glucose; Cardiovascular Diseases; Chemokine | 2014 |
[Alpha-glucosidase inhibitor for the prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese subjects with impaired glucose tolerance].
Topics: Asian People; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Disease Progression; Enzyme Inhibi | 2009 |
Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study.
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; | 2005 |
Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study.
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; | 2005 |
Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study.
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; | 2005 |
Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study.
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; | 2005 |
10 other studies available for inositol and Cardiovascular Diseases
| Article | Year |
|---|---|
Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.
Topics: Animals; Calcinosis; Cardiovascular Diseases; Cholecalciferol; Disease Models, Animal; Disease Progr | 2018 |
The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
Topics: Adult; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; | 2013 |
[Results of inositol-nicotinic acid therapy in the treatment of blood circulation disorders].
Topics: Cardiovascular Diseases; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular D | 1959 |
[On the appropriate treatment of peripheral circulation disorders in private practice].
Topics: Cardiovascular Diseases; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Private Pr | 1960 |
[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
Topics: Administration, Oral; Cardiovascular Diseases; Cyclohexanes; Diabetes Complications; Diabetes Mellit | 2004 |
Serum-free and protein-bound sugars and cardiovascular complications in diabetes mellitus.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Blood Glucose; Blood Pressure; Cardiovascular Diseas | 1976 |
[Indications for Veno-Hexanicit in surgical practice].
Topics: Aged; Amino Alcohols; Cardiovascular Diseases; Drug Combinations; Female; Fractures, Bone; Humans; I | 1971 |
[Effective and without side effects blood circulation therapy with Vascunicol].
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Ethanolamines; Female; Humans; Inositol; Male; M | 1971 |
[Drug therapy of peripheral and central vascular diseases].
Topics: Cardiovascular Diseases; Humans; Inositol; Nicotinic Acids; Regional Blood Flow; Vascular Diseases | 1970 |
[On the uptake and effect of hexanicotinic acid-esters of meso-inosit in the body].
Topics: Cardiovascular Diseases; Humans; Injections, Intravenous; Inositol; Nicotinic Acids | 1966 |